284 related articles for article (PubMed ID: 19515009)
1. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.
Zaru M; Sinico C; De Logu A; Caddeo C; Lai F; Manca ML; Fadda AM
J Liposome Res; 2009; 19(1):68-76. PubMed ID: 19515009
[TBL] [Abstract][Full Text] [Related]
2. Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.
Changsan N; Nilkaeo A; Pungrassami P; Srichana T
J Drug Target; 2009 Dec; 17(10):751-62. PubMed ID: 19863196
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
Vyas SP; Quraishi S; Gupta S; Jaganathan KS
Int J Pharm; 2005 May; 296(1-2):12-25. PubMed ID: 15885451
[TBL] [Abstract][Full Text] [Related]
4. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
5. Liposome-encapsulated antibiotics.
Salem II; Flasher DL; Düzgüneş N
Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386
[TBL] [Abstract][Full Text] [Related]
6. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary effects of chronic exposure to liposome aerosols in mice.
Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
[TBL] [Abstract][Full Text] [Related]
8. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
9. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
10. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
Vyas SP; Kannan ME; Jain S; Mishra V; Singh P
Int J Pharm; 2004 Jan; 269(1):37-49. PubMed ID: 14698575
[TBL] [Abstract][Full Text] [Related]
11. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Sato K; Ogasawara K; Akaki T; Tomioka H
Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
[TBL] [Abstract][Full Text] [Related]
12. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
[TBL] [Abstract][Full Text] [Related]
13. Liposomes for drug delivery to the lungs by nebulization.
Zaru M; Mourtas S; Klepetsanis P; Fadda AM; Antimisiaris SG
Eur J Pharm Biopharm; 2007 Nov; 67(3):655-66. PubMed ID: 17540552
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H
J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883
[TBL] [Abstract][Full Text] [Related]
15. Intracellular distribution of fluorescent probes delivered by vesicles of different lipidic composition.
Manconi M; Isola R; Falchi AM; Sinico C; Fadda AM
Colloids Surf B Biointerfaces; 2007 Jun; 57(2):143-51. PubMed ID: 17339103
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
[TBL] [Abstract][Full Text] [Related]
17. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.
Chono S; Tanino T; Seki T; Morimoto K
J Control Release; 2008 Apr; 127(1):50-8. PubMed ID: 18230410
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activity of bacteriocins and their complexes with liposomes.
Sosunov V; Mischenko V; Eruslanov B; Svetoch E; Shakina Y; Stern N; Majorov K; Sorokoumova G; Selishcheva A; Apt A
J Antimicrob Chemother; 2007 May; 59(5):919-25. PubMed ID: 17347179
[TBL] [Abstract][Full Text] [Related]
19. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
Changsan N; Chan HK; Separovic F; Srichana T
J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
